Keh (left) and Diong are of the opinion that the impact of TPPA on the local pharmaceutical industry is not as big as expected. Photo: The Star/Faihan Ghani
Increased drug prices has been one of the main concerns related to the Trans-Pacific Partnership Agreement (TPPA) – in Malaysia, as well as in the other 11 countries involved.
Fears that the Intellectual Property section of the agreement would enable medicine patent-holders to maintain their monopoly for a longer period of time have been spreading ever since drafts of the agreement were leaked, beginning in 2013.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
